Bill Text: IL HB3042 | 2011-2012 | 97th General Assembly | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Amends the Illinois Controlled Substances Act. Adds 3 synthetic cannabinoids to the list of Schedule I substances. Effective immediately.

Spectrum: Bipartisan Bill

Status: (Passed) 2011-07-22 - Public Act . . . . . . . . . 97-0194 [HB3042 Detail]

Download: Illinois-2011-HB3042-Introduced.html


97TH GENERAL ASSEMBLY
State of Illinois
2011 and 2012
HB3042

Introduced , by Rep. Robert W. Pritchard

SYNOPSIS AS INTRODUCED:
720 ILCS 570/204 from Ch. 56 1/2, par. 1204

Amends the Illinois Controlled Substances Act. Adds 3 synthetic cannabinoids to the list of Schedule I substances. Effective immediately.
LRB097 03114 RLC 51404 b
CORRECTIONAL BUDGET AND IMPACT NOTE ACT MAY APPLY

A BILL FOR

HB3042LRB097 03114 RLC 51404 b
1 AN ACT concerning criminal law.
2 Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
4 Section 5. The Illinois Controlled Substances Act is
5amended by changing Section 204 as follows:
6 (720 ILCS 570/204) (from Ch. 56 1/2, par. 1204)
7 Sec. 204. (a) The controlled substances listed in this
8Section are included in Schedule I.
9 (b) Unless specifically excepted or unless listed in
10another schedule, any of the following opiates, including their
11isomers, esters, ethers, salts, and salts of isomers, esters,
12and ethers, whenever the existence of such isomers, esters,
13ethers and salts is possible within the specific chemical
14designation:
15 (1) Acetylmethadol;
16 (1.1) Acetyl-alpha-methylfentanyl
17 (N-[1-(1-methyl-2-phenethyl)-
18 4-piperidinyl]-N-phenylacetamide);
19 (2) Allylprodine;
20 (3) Alphacetylmethadol, except
21 levo-alphacetylmethadol (also known as levo-alpha-
22 acetylmethadol, levomethadyl acetate, or LAAM);
23 (4) Alphameprodine;

HB3042- 2 -LRB097 03114 RLC 51404 b
1 (5) Alphamethadol;
2 (6) Alpha-methylfentanyl
3 (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
4 propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-
5 propanilido) piperidine;
6 (6.1) Alpha-methylthiofentanyl
7 (N-[1-methyl-2-(2-thienyl)ethyl-
8 4-piperidinyl]-N-phenylpropanamide);
9 (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
10 (7.1) PEPAP
11 (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
12 (8) Benzethidine;
13 (9) Betacetylmethadol;
14 (9.1) Beta-hydroxyfentanyl
15 (N-[1-(2-hydroxy-2-phenethyl)-
16 4-piperidinyl]-N-phenylpropanamide);
17 (10) Betameprodine;
18 (11) Betamethadol;
19 (12) Betaprodine;
20 (13) Clonitazene;
21 (14) Dextromoramide;
22 (15) Diampromide;
23 (16) Diethylthiambutene;
24 (17) Difenoxin;
25 (18) Dimenoxadol;
26 (19) Dimepheptanol;

HB3042- 3 -LRB097 03114 RLC 51404 b
1 (20) Dimethylthiambutene;
2 (21) Dioxaphetylbutyrate;
3 (22) Dipipanone;
4 (23) Ethylmethylthiambutene;
5 (24) Etonitazene;
6 (25) Etoxeridine;
7 (26) Furethidine;
8 (27) Hydroxpethidine;
9 (28) Ketobemidone;
10 (29) Levomoramide;
11 (30) Levophenacylmorphan;
12 (31) 3-Methylfentanyl
13 (N-[3-methyl-1-(2-phenylethyl)-
14 4-piperidyl]-N-phenylpropanamide);
15 (31.1) 3-Methylthiofentanyl
16 (N-[(3-methyl-1-(2-thienyl)ethyl-
17 4-piperidinyl]-N-phenylpropanamide);
18 (32) Morpheridine;
19 (33) Noracymethadol;
20 (34) Norlevorphanol;
21 (35) Normethadone;
22 (36) Norpipanone;
23 (36.1) Para-fluorofentanyl
24 (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
25 4-piperidinyl]propanamide);
26 (37) Phenadoxone;

HB3042- 4 -LRB097 03114 RLC 51404 b
1 (38) Phenampromide;
2 (39) Phenomorphan;
3 (40) Phenoperidine;
4 (41) Piritramide;
5 (42) Proheptazine;
6 (43) Properidine;
7 (44) Propiram;
8 (45) Racemoramide;
9 (45.1) Thiofentanyl
10 (N-phenyl-N-[1-(2-thienyl)ethyl-
11 4-piperidinyl]-propanamide);
12 (46) Tilidine;
13 (47) Trimeperidine;
14 (48) Beta-hydroxy-3-methylfentanyl (other name:
15 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
16 N-phenylpropanamide).
17 (c) Unless specifically excepted or unless listed in
18another schedule, any of the following opium derivatives, its
19salts, isomers and salts of isomers, whenever the existence of
20such salts, isomers and salts of isomers is possible within the
21specific chemical designation:
22 (1) Acetorphine;
23 (2) Acetyldihydrocodeine;
24 (3) Benzylmorphine;
25 (4) Codeine methylbromide;
26 (5) Codeine-N-Oxide;

HB3042- 5 -LRB097 03114 RLC 51404 b
1 (6) Cyprenorphine;
2 (7) Desomorphine;
3 (8) Diacetyldihydromorphine (Dihydroheroin);
4 (9) Dihydromorphine;
5 (10) Drotebanol;
6 (11) Etorphine (except hydrochloride salt);
7 (12) Heroin;
8 (13) Hydromorphinol;
9 (14) Methyldesorphine;
10 (15) Methyldihydromorphine;
11 (16) Morphine methylbromide;
12 (17) Morphine methylsulfonate;
13 (18) Morphine-N-Oxide;
14 (19) Myrophine;
15 (20) Nicocodeine;
16 (21) Nicomorphine;
17 (22) Normorphine;
18 (23) Pholcodine;
19 (24) Thebacon.
20 (d) Unless specifically excepted or unless listed in
21another schedule, any material, compound, mixture, or
22preparation which contains any quantity of the following
23hallucinogenic substances, or which contains any of its salts,
24isomers and salts of isomers, whenever the existence of such
25salts, isomers, and salts of isomers is possible within the
26specific chemical designation (for the purposes of this

HB3042- 6 -LRB097 03114 RLC 51404 b
1paragraph only, the term "isomer" includes the optical,
2position and geometric isomers):
3 (1) 3,4-methylenedioxyamphetamine
4 (alpha-methyl,3,4-methylenedioxyphenethylamine,
5 methylenedioxyamphetamine, MDA);
6 (1.1) Alpha-ethyltryptamine
7 (some trade or other names: etryptamine;
8 MONASE; alpha-ethyl-1H-indole-3-ethanamine;
9 3-(2-aminobutyl)indole; a-ET; and AET);
10 (2) 3,4-methylenedioxymethamphetamine (MDMA);
11 (2.1) 3,4-methylenedioxy-N-ethylamphetamine
12 (also known as: N-ethyl-alpha-methyl-
13 3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
14 and MDEA);
15 (2.2) N-Benzylpiperazine (BZP);
16 (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
17 (4) 3,4,5-trimethoxyamphetamine (TMA);
18 (5) (Blank);
19 (6) Diethyltryptamine (DET);
20 (7) Dimethyltryptamine (DMT);
21 (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
22 (9) Ibogaine (some trade and other names:
23 7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
24 6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
25 indole; Tabernanthe iboga);
26 (10) Lysergic acid diethylamide;

HB3042- 7 -LRB097 03114 RLC 51404 b
1 (10.5) Salvia divinorum (meaning all parts of the plant
2 presently classified botanically as Salvia divinorum,
3 whether growing or not, the seeds thereof, any extract from
4 any part of that plant, and every compound, manufacture,
5 salts, isomers, and salts of isomers whenever the existence
6 of such salts, isomers, and salts of isomers is possible
7 within the specific chemical designation, derivative,
8 mixture, or preparation of that plant, its seeds or
9 extracts);
10 (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
11 (12) Peyote (meaning all parts of the plant presently
12 classified botanically as Lophophora williamsii Lemaire,
13 whether growing or not, the seeds thereof, any extract from
14 any part of that plant, and every compound, manufacture,
15 salts, derivative, mixture, or preparation of that plant,
16 its seeds or extracts);
17 (13) N-ethyl-3-piperidyl benzilate (JB 318);
18 (14) N-methyl-3-piperidyl benzilate;
19 (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
20 (also known as N-hydroxy-alpha-methyl-
21 3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
22 (15) Parahexyl; some trade or other names:
23 3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
24 dibenzo (b,d) pyran; Synhexyl;
25 (16) Psilocybin;
26 (17) Psilocyn;

HB3042- 8 -LRB097 03114 RLC 51404 b
1 (18) Alpha-methyltryptamine (AMT);
2 (19) 2,5-dimethoxyamphetamine
3 (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
4 (20) 4-bromo-2,5-dimethoxyamphetamine
5 (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
6 4-bromo-2,5-DMA);
7 (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
8 Some trade or other names: 2-(4-bromo-
9 2,5-dimethoxyphenyl)-1-aminoethane;
10 alpha-desmethyl DOB, 2CB, Nexus;
11 (21) 4-methoxyamphetamine
12 (4-methoxy-alpha-methylphenethylamine;
13 paramethoxyamphetamine; PMA);
14 (22) (Blank);
15 (23) Ethylamine analog of phencyclidine.
16 Some trade or other names:
17 N-ethyl-1-phenylcyclohexylamine,
18 (1-phenylcyclohexyl) ethylamine,
19 N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
20 (24) Pyrrolidine analog of phencyclidine. Some trade
21 or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy,
22 PHP;
23 (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
24 (26) 2,5-dimethoxy-4-ethylamphetamine
25 (another name: DOET);
26 (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine

HB3042- 9 -LRB097 03114 RLC 51404 b
1 (another name: TCPy);
2 (28) (Blank);
3 (29) Thiophene analog of phencyclidine (some trade
4 or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
5 2-thienyl analog of phencyclidine; TPCP; TCP);
6 (30) Bufotenine (some trade or other names:
7 3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
8 3-(2-dimethylaminoethyl)-5-indolol;
9 5-hydroxy-N,N-dimethyltryptamine;
10 N,N-dimethylserotonin; mappine);
11 (31) 1-Pentyl-3-(1-naphthoyl)indole
12 Some trade or other names: JWH-018;
13 (32) 1-Butyl-3-(1-naphthoyl)indole
14 Some trade or other names: JWH-073; .
15 (33) 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-
16 hydroxycyclohexyl]-phenol (CP-47,497);
17 (34) 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-
18 hydroxycyclohexyl]-phenol (cannabicyclohexanol);
19 (35) 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole
20 (JWH-200).
21 (e) Unless specifically excepted or unless listed in
22another schedule, any material, compound, mixture, or
23preparation which contains any quantity of the following
24substances having a depressant effect on the central nervous
25system, including its salts, isomers, and salts of isomers
26whenever the existence of such salts, isomers, and salts of

HB3042- 10 -LRB097 03114 RLC 51404 b
1isomers is possible within the specific chemical designation:
2 (1) mecloqualone;
3 (2) methaqualone; and
4 (3) gamma hydroxybutyric acid.
5 (f) Unless specifically excepted or unless listed in
6another schedule, any material, compound, mixture, or
7preparation which contains any quantity of the following
8substances having a stimulant effect on the central nervous
9system, including its salts, isomers, and salts of isomers:
10 (1) Fenethylline;
11 (2) N-ethylamphetamine;
12 (3) Aminorex (some other names:
13 2-amino-5-phenyl-2-oxazoline; aminoxaphen;
14 4-5-dihydro-5-phenyl-2-oxazolamine) and its
15 salts, optical isomers, and salts of optical isomers;
16 (4) Methcathinone (some other names:
17 2-methylamino-1-phenylpropan-1-one;
18 Ephedrone; 2-(methylamino)-propiophenone;
19 alpha-(methylamino)propiophenone; N-methylcathinone;
20 methycathinone; Monomethylpropion; UR 1431) and its
21 salts, optical isomers, and salts of optical isomers;
22 (5) Cathinone (some trade or other names:
23 2-aminopropiophenone; alpha-aminopropiophenone;
24 2-amino-1-phenyl-propanone; norephedrone);
25 (6) N,N-dimethylamphetamine (also known as:
26 N,N-alpha-trimethyl-benzeneethanamine;

HB3042- 11 -LRB097 03114 RLC 51404 b
1 N,N-alpha-trimethylphenethylamine);
2 (7) (+ or -) cis-4-methylaminorex ((+ or -) cis-
3 4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine).
4 (g) Temporary listing of substances subject to emergency
5scheduling. Any material, compound, mixture, or preparation
6that contains any quantity of the following substances:
7 (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
8 (benzylfentanyl), its optical isomers, isomers, salts,
9 and salts of isomers;
10 (2) N-[1(2-thienyl)
11 methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
12 its optical isomers, salts, and salts of isomers.
13(Source: P.A. 95-239, eff. 1-1-08; 95-331, eff. 8-21-07;
1496-347, eff. 1-1-10; 96-1285, eff. 1-1-11.)
15 Section 99. Effective date. This Act takes effect upon
16becoming law.
feedback